Health and Fitness Health and Fitness
Mon, February 28, 2011
Sun, February 27, 2011
Fri, February 25, 2011
Thu, February 24, 2011
Wed, February 23, 2011
Tue, February 22, 2011
[ Tue, Feb 22nd 2011 ] - Market Wire
PROTOX APPOINTS NEW DIRECTORS
Mon, February 21, 2011
Sun, February 20, 2011
Fri, February 18, 2011
Thu, February 17, 2011
Wed, February 16, 2011
Tue, February 15, 2011
Mon, February 14, 2011
Fri, February 11, 2011
Thu, February 10, 2011

SuperGen to Announce 2010 Fourth Quarter and Year-End Financial Results on February 28, 2011


//health-fitness.news-articles.net/content/2011/ .. r-end-financial-results-on-february-28-2011.html
Published in Health and Fitness on Tuesday, February 22nd 2011 at 3:20 GMT by Market Wire   Print publication without navigation


DUBLIN, Calif.--([ BUSINESS WIRE ])--SuperGen, Inc. (Nasdaq:SUPG), a pharmaceutical company dedicated to discovery and development of novel cancer therapies, announced that it will release its 2010 fourth quarter and fiscal year-end results on Monday, February 28, 2011. SuperGen's management team will provide details of the Company's financial results, and provide financial guidance for fiscal year 2011.

A press release will be issued following the close of the market on February 28th. The Company will host a webcast conference call to discuss the results at 4:30 p.m. ET. A live webcast of the call will be available in the Investor Events section of the Company's Web site at [ www.supergen.com ]. A webcast replay of the live conference call will be available shortly following the event. Alternatively, you may access a replay of the conference call by dialing (800) 642-1687 (domestic) and (706) 645-9291 (international); replay passcode number is 46514688. The webcast replay and conference call replay will be available for 30 days.

About SuperGen

SuperGen is a pharmaceutical company dedicated to discovery and development of novel cancer therapeutics in epigenetic and cell signaling modulation. The Company develops products through biochemical and clinical proof of concept to partner for further development and commercialization. For more information about SuperGen, please visit [ http://www.supergen.com ].


Publication Contributing Sources